2 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Nov 26, 2024
Read More Medical UK Launches First Clinical Trial Of Proton Beam Therapy For Breast Cancer To Help Patients Reduce The Risk Of Heart Problems Caused By Radiotherapy Dec 23, 2024
Read More Apparatus Study Confirms Widespread Presence Of Nectin-4 Target In Head And Neck Cancer, ADC Drug In Play! Dec 18, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Dec 09, 2024
Read More Apparatus The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise! Dec 15, 2024
